Search Results - "Hays, S.M."

Refine Results
  1. 1

    Biomonitoring equivalents: A screening approach for interpreting biomonitoring results from a public health risk perspective by Hays, S.M., Becker, R.A., Leung, H.W., Aylward, L.L., Pyatt, D.W.

    Published in Regulatory toxicology and pharmacology (01-02-2007)
    “…Advances in both sensitivity and specificity of analytical chemistry have made it possible to quantify substances in human biological specimens, such as blood,…”
    Get full text
    Journal Article
  2. 2

    Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium by Kirman, C.R., Hays, S.M., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., Haws, L.C., Proctor, D.M.

    Published in Chemico-biological interactions (25-10-2012)
    “…► A PBPK model was developed for oral Cr in rodents that includes the GI tract. ► Target tissue Cr data were collected in rodents exposed to Cr(VI) for 90days…”
    Get full text
    Journal Article
  3. 3

    Physiologically based pharmacokinetic model for humans orally exposed to chromium by Kirman, C.R., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., Haws, L.C., Proctor, D.M., Lin, S.S., Parker, W., Hays, S.M.

    Published in Chemico-biological interactions (25-06-2013)
    “…•Human gastric fluid samples were collected to measure Cr(VI) reduction.•Cr(VI) reduction is pH-dependent, mixed second order, and capacity limited.•A human…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxide by Kirman, C.R., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-12-2017)
    “…An approach is presented for ethylene oxide (EO) to derive endogenous equivalent (EE) values, which are endogenous levels normally found within the body…”
    Get full text
    Journal Article
  6. 6

    Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts by Anderson, J.K., Brecher, R.W., Cousins, I.T., DeWitt, J., Fiedler, H., Kannan, K., Kirman, C.R., Lipscomb, J., Priestly, B., Schoeny, R., Seed, J., Verner, M., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-10-2022)
    “…An expert panel was convened to provide insight and guidance on per- and polyfluoroalkyl substances (PFAS) grouping for the purposes of protecting human health…”
    Get full text
    Journal Article
  7. 7

    Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias by Kirman, C.R., Simon, T.W., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-04-2019)
    “…Science peer review plays an important role in the advancement and acceptance of scientific information, particularly when used to support decision-making. A…”
    Get full text
    Journal Article
  8. 8

    Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadiene by Kirman, C.R., North, C.M., Tretyakova, N.Y., Erraguntla, N., Shen, H., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-10-2022)
    “…Subchronic and chronic reference values (RfVs) were derived for 1,3-butadiene (BD) based upon its ability to cause reproductive and developmental effects…”
    Get full text
    Journal Article
  9. 9

    Derivation of no significant risk levels for three lower acrylates: Conclusions and recommendations from an expert panel by Kirman, C.R., Boogaard, P.J., Bus, J.S., Dellarco, V.L., Shao, K., Stern, B.R., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-03-2024)
    “…A panel of toxicology, mode of action (MOA), and cancer risk assessment experts was engaged to derive no-significant-risk-levels (NSRLs) for three lower…”
    Get full text
    Journal Article
  10. 10

    A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review by Juberg, D.R., Fox, D.A., Forcelli, P.A., Kacew, S., Lipscomb, J.C., Saghir, S.A., Sherwin, C.M., Koenig, C.M., Hays, S.M., Kirman, C.R.

    Published in Regulatory toxicology and pharmacology (01-09-2023)
    “…For decades, there has been increasing concern about the potential developmental neurotoxicity (DNT) associated with chemicals. Regulatory agencies have…”
    Get full text
    Journal Article
  11. 11

    Cancer weight of evidence for three lower acrylates: Conclusions and recommendations from an expert panel by Kirman, C.R., Boogaard, P.J., Bus, J.S., Dellarco, V.L., DePass, L.R., Stern, B.R., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-09-2023)
    “…An international panel of experts was engaged to assess the cancer weight of evidence (WOE) for three lower acrylates: methyl acrylate, ethyl acrylate, and…”
    Get full text
    Journal Article
  12. 12

    Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations by Kirman, C.R., Suh, M., Proctor, D.M., Hays, S.M.

    Published in Toxicology and applied pharmacology (15-06-2017)
    “…A physiologically based pharmacokinetic (PBPK) model for hexavalent chromium [Cr(VI)] in mice, rats, and humans developed previously (Kirman et al., 2012,…”
    Get full text
    Journal Article
  13. 13

    Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data by Aylward, L.L., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-12-2015)
    “…Urinary biomonitoring data for 2,4-dichlorophenoxyacetic acid (2,4-D) reflect aggregate population exposures to trace 2,4-D residues in diet and the…”
    Get full text
    Journal Article
  14. 14

    An evaluation of reproductive toxicity studies and data interpretation of N-methylpyrrolidone for risk assessment: An expert panel review by Kirman, C.R., Sonawane, B.R., Seed, J.G., Azu, N.O., Barranco, W.T., Hamilton, W.R., Stedeford, T.J., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-02-2023)
    “…An expert panel was assembled to evaluate reproductive toxicology study data and their application to health risk assessment to provide input on the data…”
    Get full text
    Journal Article
  15. 15

    Biomonitoring Equivalents for interpretation of urinary fluoride by Aylward, L.L., Hays, S.M., Vezina, A., Deveau, M., St-Amand, A., Nong, A.

    Published in Regulatory toxicology and pharmacology (01-06-2015)
    “…•Fluoride exposures can be effectively quantified via urinary biomonitoring.•Biomonitoring Equivalents (BE) are levels consistent with exposure guidance…”
    Get full text
    Journal Article
  16. 16

    Biomonitoring Equivalents for cyanide by Kirman, C.R., Belknap, A.M., Webster, A.F., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-08-2018)
    “…Exposure to cyanide is widespread in human populations due to a variety of natural and anthropogenic sources. The potential health risks of excess cyanide…”
    Get full text
    Journal Article
  17. 17

    Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine by Kirman, C.R., Hughes, B., Becker, R.A., Hays, S.M.

    Published in Regulatory toxicology and pharmacology (01-04-2016)
    “…Diethanolamine (DEA) has been found to produce liver and kidney tumors in mice following lifetime dermal exposures. Data regarding the mode of action by which…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Pine needles--a hot, new commodity by Hays, S.M

    Published in Agricultural research (Washington) (01-05-1996)
    “…Catalino Blanche suggests that pine needles be harvested and sold, since they are a hot commodity among landscapers and builders. Pine straw harvesting is very…”
    Get full text
    Magazine Article